Piramal Pharma (NSE:PPLPHARMA) Ending Cash Position : ₹0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Ending Cash Position?

Piramal Pharma's Ending Cash Position for the quarter that ended in Mar. 2024 was ₹0 Mil.

Piramal Pharma's annual Ending Cash Position declined from Mar. 2022 (₹852 Mil) to Mar. 2023 (₹532 Mil) but then increased from Mar. 2023 (₹532 Mil) to Mar. 2024 (₹2,192 Mil).

Piramal Pharma Ending Cash Position Historical Data

The historical data trend for Piramal Pharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Ending Cash Position Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

1,467.30

851.80

532.30

2,191.90

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial							-	-	-	-	-

Piramal Pharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Piramal Pharma's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	532.3	+	1659.6
	=	2,192

Piramal Pharma's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

Piramal Pharma Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Ending Cash Position

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines